Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Amra uses cloud-based, computer aided service to analytically transform MR images into body composition measurements.
Ixchelsis develops an oxytocin receptor antagonist for the treatment of premature ejaculation.
Our lead program addresses significant unmet needs in the field of Type 1 Diabetes
Ziarco develops therapeutic agents for treating inflammatory and allergic diseases.
Pfizer Venture Investments has invested in 53 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Pfizer Venture Investments's top investment sectors include Biotechnology, Medical Device, Therapeutics, Health Care, Hospital. The firm invests across 6 different industry categories.
Among tracked funding rounds, Ziarco received $33.0M in a Series B round. Pfizer Venture Investments's total known invested capital is $2.4B.
Pfizer Venture Investments's average investment size is $44.8M across its portfolio of 53 companies.